Top cited articles

To celebrate another year of high quality, cutting edge content published in Lupus Science & Medicine®, we have shortlisted the most cited papers of the past 2 years.

Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-lpr mice
APR 2020 10.1136/lupus-2020-000387

Prediction of prognosis and renal outcome in lupus nephritis
FEB 2020 10.1136/lupus-2020-000389

Similar progression of carotid intima-media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher prednisolone usage in patients
JAN 2020 10.1136/lupus-2019-000362

Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease
JUNE 2020 10.1136/lupus-2020-000394

Measurement properties of selected patient-reported outcome measures for use in randomised controlled trials in patients with systemic lupus erythematosus: a systematic review
JUNE 2020 10.1136/lupus-2019-000373

Towards a practical management of fatigue in systemic lupus erythematosus
NOV 2020 10.1136/lupus-2020-000441

Anti-Mullerian hormone in African-American women with systemic lupus erythematosus
NOV 2020 10.1136/lupus-2020-000439

Systemic lupus erythematosus and neutropaenia: a hallmark of haematological manifestations
JUL 2020 10.1136/lupus-2020-000399

Disease duration, age at diagnosis and organ damage are important factors for cardiovascular disease in SLE
JUN 2020 10.1136/lupus-2020-000398

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
JUN 2020 10.1136/lupus-2019-000375</span